Display Settings:

Format

Send to:

Choose Destination
    Breast Cancer Res Treat. 2005 Feb;89(3):309-12.

    HER2 codon 655 polymorphism and breast cancer: results from kin-cohort and case-control analyses.

    Source

    Department of Epidemiology, School of Public Health, University of North Carolina, CB #7435, Chapel Hill, NC 27599-7435, USA. millikan@email.unc.edu

    Abstract

    Several published epidemiologic studies show increased breast cancer risk for carriers of the Val-allele at codon 655 of the HER2 gene. We conducted additional analyses using data from three studies, including case-control analyses stratified on age and kin-cohort analyses using relatives of cases and controls. The results provide additional evidence that HER2 codon 655 genotype may predispose to early-onset breast cancer.

    PMID:
    15754131
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Springer

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk